Sort
172,184 grants matching “inflammation”
Improved Dosing and Refinement of a Cardiac Targeted Gene Therapy in a Swine Infarct Model
$1,545,537Sam Teichman · Beat Biotherapeutics Corporation · R44 · FY2016 · HL
MECHANISM OF INFLAMMATION INDUCED AIRWAY HYPERREACTIVITY
$1,545,223Johns Hopkins University · P01 · FY2001 · HL
Multidimensional predictive modeling to understand mechanisms of exercise response heterogeneity in older adults
$1,545,208Marcas M Bamman · Florida Institu /Human/Machine Cognition · R01 · FY2024 · AG
Realizing Effectiveness Across Continents with Hydroxyurea(REACH): A Phase I/II Pilot Study of Hyroxyurea for Children with Sickle Cell Anemia
$1,545,130Russell E Ware · Cincinnati Childrens Hosp Med Ctr · U01 · FY2022 · HL
Gene networks controlling macrophage-adipocyte interactions in insulin resistance
$1,545,000Christopher K Glass · University Of California, San Diego · P01 · FY2007 · DK
"NOVEL GENETIC MODELS TO STUDY THE ROLE OF INFLAMMATION IN BRAIN INJURY-INDUCED ALZHEIEMER'S PATHOLGY"
$1,545,000The Cleveland Clinic Foundation · · FY2012 · Department of Defense
Environmental Agents as Modulators of Disease Processes
$1,544,711Thomas A Gasiewicz · University Of Rochester · P30 · FY2008 · ES
Sensory Biology
$1,544,534Nicholas J Ryba · National Institute Of Dental & Craniofacial Research · ZIA · FY2020 · DE
Molecular Biology of Hemorrhagic Schock
$1,544,511University Of Pittsburgh At Pittsburgh · P50 · FY2004 · GM
Nonalcoholic Steatohepatitis: Natural History, Pathogenesis and Therapy
$1,544,379Yaron Rotman · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK
Sirtuins and nuclear receptors in aging and age-associated diseases
$1,544,197Xiaoling Li · National Institute Of Environmental Health Sciences · ZIA · FY2010 · ES
Clonal analysis of in vivo hematopoiesis
$1,543,957Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL
VASCULAR RELATIONS OF BLOOD CELLS AND PROTEINS
$1,543,622University Of Rochester · P01 · FY2001 · HL
Lung Endothelial Cell Phenotypes
$1,543,601Troy Stevens · University Of South Alabama · P01 · FY2009 · HL
ETHER LIPIDS, EICOSANOIDS AND LUNG CELL PATHOPHYSIOLOGY
$1,543,592National Jewish Health · P01 · FY2000 · HL
Diabetes Research Center
$1,543,570Steven E Kahn · University Of Washington · P30 · FY2013 · DK
Pathophysiologic and Therapeutic Mechanisms in Aspirin Exacerbated Respiratory Disease
$1,543,357Joshua A Boyce · Brigham And Women'S Hospital · U19 · FY2016 · AI
Pathophysiologic and Therapeutic Mechanisms in Aspirin Exacerbated Respiratory Disease
$1,543,357Joshua A Boyce · Brigham And Women'S Hospital · U19 · FY2018 · AI
Pathophysiologic and Therapeutic Mechanisms in Aspirin Exacerbated Respiratory Disease
$1,543,357Joshua A Boyce · Brigham And Women'S Hospital · U19 · FY2019 · AI
Pathophysiologic and Therapeutic Mechanisms in Aspirin Exacerbated Respiratory Disease
$1,543,357Joshua A Boyce · Brigham And Women'S Hospital · U19 · FY2020 · AI
Thrombus Formation and Antithrombotic Intervention
$1,543,323John H Griffin · Scripps Research Institute, The · P01 · FY2013 · HL
NEURONAL AND CHEMICAL CONTROL OF BREATHING AN AIRWAYS FU
$1,543,189Howard University · U54 · FY2003 · NS
POTENTIAL FOR ENVIRONMENTAL AND THERAPEUTIC AGENTS TO INDUCE IMMUNOTOXICITY
$1,543,099Kimber White · Virginia Commonwealth University · N01 · FY2010 · ES
A TRIAL OF TTP488 TO SLOW THE RATE OF CLINICAL PROGRESSION OF PATIENTS WITH AD
$1,543,069Douglas R Galasko · University Of California, San Diego · U01 · FY2007 · AG
Ancillary Studies of NAFLD and NASH in HIV infected Adults
$1,542,615Naga P. Chalasani · Indiana University Indianapolis · R01 · FY2023 · DK